Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Sumatriptan recalled?

Not under an active recall. Sumatriptan was recalled 9 times in the past — all now closed. Most recent: Apr 13, 2022.

Most common reason: Impurity / degradation (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Sumatriptan. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Sumatriptan recalls on record

none so far in 2026; 9 on record, newest first
Class II · Moderate risk

Sumatriptan Succinate Tablets

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

Terminated Impurity / degradation Sun Pharmaceutical Industries, Inc. D-0660-2020
Class II · Moderate risk

Sumatriptan Succinate Tablets

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

Terminated Impurity / degradation Sun Pharmaceutical Industries, Inc. NDC 62756-521-69 D-0659-2020
Class II · Moderate risk

Sumatriptan USP for prescription compounding

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8089-3 D-0522-2018
Class II · Moderate risk

Sumatriptan Succinate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-909-2015
Class II · Moderate risk

Sumatriptan Succinate Injection

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Terminated Sterility / contamination GlaxoSmithKline, LLC. NDC 0781-3173-07 D-388-2014
Class II · Moderate risk

Imitrex STATdose System

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Terminated Sterility / contamination GlaxoSmithKline, LLC. NDC 0173-0479-00 D-387-2014